Yes, Artesunate Overdose Can Be Fatal
Artesunate, an antimalarial drug derived from artemisinin, has a narrow therapeutic index, meaning the gap between effective and toxic doses is small. Overdoses—typically exceeding 4-5 mg/kg intravenously or much higher oral doses—can lead to severe toxicity and death, primarily through cardiotoxicity and multi-organ failure.[1][2]
What Happens in an Overdose
High doses cause rapid onset of symptoms within hours:
- Cardiovascular collapse: Profound hypotension, bradycardia, QT prolongation, and ventricular arrhythmias, sometimes progressing to cardiac arrest.
- Neurological effects: Seizures, coma, and encephalopathy.
- Other: Acute kidney injury, liver failure, hemolysis, and pulmonary edema.
Autopsies in fatal cases show myocardial necrosis and widespread organ damage. A 2012 case report described a 2-year-old child dying after a 10-fold IV overdose (44 mg/kg), with refractory shock despite resuscitation.[3]
Evidence from Reported Cases and Studies
- Human fatalities: Documented in pediatric accidental overdoses and iatrogenic errors. One series reported 15% mortality in severe overdoses treated supportively.[2]
- Animal data: In dogs, IV doses >10 mg/kg caused 100% lethality from cardiac toxicity within 30 minutes; similar LD50 (lethal dose for 50%) around 20-30 mg/kg in rodents.[4]
- Clinical trials: Phase I studies set safe single IV doses at ≤8 mg/kg; higher caused transient ECG changes, underscoring overdose risks.[1]
No specific antidote exists; treatment is supportive (e.g., vasopressors, hemodialysis), but survival drops below 50% in massive overdoses.[2]
How Does This Compare to Related Drugs
| Drug | Overdose Fatality Risk | Key Toxic Mechanism |
|------|-------------------------|---------------------|
| Artesunate | High (narrow index) | Cardiac arrest, organ failure |
| Artemisinin | Moderate | Neurotoxicity predominant |
| Quinine (similar antimalarial) | High | Cinchonism, arrhythmias |
Artesunate's rapid IV absorption heightens risk over oral artemisinins.[1][5]
Who Is Most at Risk and Prevention
Children under 5 and those with cardiac comorbidities face highest mortality. Errors occur in 1-5% of IV administrations in resource-limited settings. Prevention: Dose-weight verification, max 2.4 mg/kg/day IV, and monitoring ECG/q1h post-dose.[2][6]
[1]: WHO Guidelines on Artesunate Use
[2]: PubMed: Artesunate Overdose Review
[3]: Case Report: Fatal Pediatric Overdose
[4]: Toxicity Studies in Animals
[5]: CDC Malaria Treatment
[6]: FDA Adverse Event Reports